Equity
€2.0m ▼ 0.6%
PHARMACAR paid out €324,062 in dividends. That is 104% of the 2025 profit.
PHARMACAR
Lifetime
19 annual accounts with figures on one time axis, 32 filings since 1993peak €910,012 (2020)
€510,874▼ 35.3%
lowest -€30,223 (2012)
€311,180▼ 38.6%
peak €2.0m (2024)
€2.0m▼ 0.6%
€528,237▲ 172%
peak 1 FTE (2011)
0 FTE
Board3 names since 1993
-
Documentsfilings and deeds
30-01-20261 day before the deadline
2025abbreviated format
Gross margin from €789,492 to €510,874Result from €506,619 to €311,180Dividend €324,062Debts from €194,192 to €528,237Investments €53,883
Key points
from the 2025 annual accountsResult
€311,180 ▼ 38.6%
The result fell in 2025 from €506,619 to €311,180.
Debts
€528,237 ▲ 172%
Debts rose by €334,045 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Liquidity
4.77 was 13.03 in 2024
Short-term debts rose from €165,468 to €514,295.
Filings
32 annual accounts since 1993
The last five annual accounts were filed 1 to 17 days before the end of the period.
Position in the sector
€2.0m
More equity than 89% of companies in wholesale trade. Sector median €361,107 · 9,898 companies.
Checked score
97
Excellent
Financially stronger than 74% of small companies in wholesale trade (NACE 46)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 4,374 companies (NACE 46, small).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025lowest value
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026highest value
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Founded in 1993
Liquidity: current ratio 4.77, cash €551,704
Equity €2.0m (79.4% of total assets)
Size: total assets €2.6m
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small). It does better than 92% of them on solvency, 88% on liquidity, 87% on profitability and 29% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-06-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 20,137 companies had the same profile as PHARMACAR has now. Each dot stands for 51 companies, two years later.
95.1%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
That fits the bankruptcy probability of PHARMACAR itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,137 companies, not a prediction for PHARMACAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €190,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.77 (13.03 in 2024), above the usual 1.5. Short-term debt is 20.1% and cash 21.5% of total assets. 20.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 day early
2024
17 days early
2023
15 days early
2022
1 day early
2021
4 days early
2020
2 days early
2019
21 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 9 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 27 January (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
30-06-2026 year end09-11-2026 today31-01-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0449954393
Resignation: Liesbeth Dejonghe (director)
Director discharge: Liesbeth Dejonghe · General meeting of 19-10-2021 · Gazette deed
Registered office moved to Merelbeke
New registered office: Burgemeester Maenhautstraat 59, 9820 Merelbeke (Lemberge) · Resignations: Axel Dejonghe (director) and Hilde Noterdame (director) · Reappointments: Axel Dejonghe (director) and Hilde Noterdame (director) · Gazette deed
First establishment
Burg. Maenhautstraat 59, Merelbeke-Melle
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PHARMACAR Merelbeke-Melle | €2.6m | €510,874 | 79.4% | 0 |
| GROUP WUYTS Aartselaar | €1.6m | €500,467 | 22.3% | 0 |
| I.F.H.S. Lummen | €4.3m | €681,444 | 55.8% | 0 |
| DAPAT Jabbeke | €1.8m | €370,237 | 45.5% | 0.2 |
| GITRAX Kasterlee | €1.8m | €456,802 | 60.9% | 1 |
| ROLLIN VANMEERHAEGHE FORMULA RACING Merelbeke-Melle | €1.1m | €284,242 | 88.5% | 0 |
| A.T.B. Beveren-Kruibeke-Zwijndrecht | €2.8m | €251,809 | 49.3% | 0 |
These companies have the same main activity as PHARMACAR: wholesale of motor vehicle parts and accessories (NACE 46720). They are comparable in size and age: total assets between €1.1m and €4.3m, founded between 1975 and 1999.
Official details
Source: KBO- Status
- Active since 23-04-1993Normal situation
- Activity
- Wholesale of motor vehicle parts and accessoriesNACE 46720
- Joint committee
- 200Auxiliary committee for white-collar workers · annual accounts 30-06-2022
- Establishment unit
- 2.062.212.3779820 Merelbeke-Melle, since 14-05-1993
- Financial year end
- 30 June
- Peppol
- Reachable since 01-09-2025
Annual accounts to 30-06-2025
- ≈ €2.6mestimated
- €2.6m▲ 14.3%
- Filing
- Filed on 30-01-2026, 1 day before the end of the filing period
Insights on PHARMACAR
PHARMACAR files the abbreviated format. That format states no turnover. The gross margin rose from €71,558 in 2006 to €510,874 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PHARMACAR
- What is the company number of PHARMACAR?
- The company number of PHARMACAR is 0449.954.393. The VAT number is the same number with BE in front: BE 0449.954.393.
- Where is PHARMACAR based?
- The registered office is at Burg. Maenhautstraat 59, 9820 Merelbeke-Melle.Company details
- What does PHARMACAR do?
- According to the KBO register, the main activity is wholesale of motor vehicle parts and accessories (NACE 46720).
- What is the legal form of PHARMACAR?
- PHARMACAR is a private limited company (BV).
- When was PHARMACAR founded?
- PHARMACAR was founded on 23-04-1993.
- Is PHARMACAR still active?
- Yes, PHARMACAR is an active enterprise in the KBO register.
- How many employees does PHARMACAR have?
- PHARMACAR had an average of 1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
- Which joint committee does PHARMACAR fall under?
- In its 30-06-2022 annual accounts, PHARMACAR states joint committee 200 (Auxiliary committee for white-collar workers).
- What is the turnover of PHARMACAR?
- The turnover in financial year 2025 is ≈ €2.6m. This figure is estimated from the gross margin of €510,874 and 139 comparable companies (NACE 46). It probably lies between €1.6m and €4.4m.
- Is PHARMACAR profitable?
- In financial year 2025, PHARMACAR made a profit of €311,180.
- Where can I find the annual accounts of PHARMACAR?
- PHARMACAR filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMACAR due?
- PHARMACAR must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.